Search

Search Results

• 

  Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers

  Ezio Zanon, Giancarlo Castaman, Augusto Bramante Federici, Maria Elisa Mancuso, Gianfranco Pasut, Alberto Tosetto, Angiola Rocino, Rita Carlotta Santoro

  26-01-2026

  https://doi.org/10.4081/btvb.2026.415

  1015

  PDF: 273

  HTML: 78
• 

  Gene therapy for hemophilia B

  Pier Mannuccio Mannucci

  12-12-2025

  https://doi.org/10.4081/btvb.2025.425

  572

  PDF: 51

  HTML: 36

• PO39 | Bleeding events in Von Willebrand disease type 1 yearly treatable with desmopressin A. Gringeri^1,2, P.M. Mannucci³, M. Gringeri⁴, G. Castaman⁵, F. Peyvandi^3,6 | ¹Fondazione Charta, Milan; ²Centro di Sanità Solidale, Lucca; ³Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan; ⁴Department of Medical Biotechnologies and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan; ⁵Centre for Bleeding Disorders and Coagulation, Careggi University Hospital, Firenze; ⁶Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.302

  526

  PDF: 0
• 

  Growing weapons to fight hemophilia

  Pier Mannuccio Mannucci

  23-02-2023

  https://doi.org/10.4081/btvb.2023.64

  1336

  PDF: 475
• 

  An ecological alliance against air pollution and cardiovascular disease

  Pier Mannuccio Mannucci

  22-03-2022

  https://doi.org/10.4081/btvb.2022.21

  2061

  PDF: 417
• 

  Gene transfer in hemophilia A: not cogent yet

  Pier Mannuccio Mannucci

  20-04-2022

  https://doi.org/10.4081/btvb.2022.32

  2437

  PDF: 355